TNFRSF17 and TNFRSF13B, members of the tumor necrosis factor receptor superfamily, are primarily involved in the maturation of B lymphocytes and are associated with tumor growth and invasiveness and may serve as therapeutic targets in breast cancer (Pelekanou et al., 2018). The gene discussed is TNFRSF17; the disease is breast carcinoma.